Archivserver der Deutschen Nationalbibliothek

90. Ormiston JA, Webster MW, Armstrong G. First-in-human implantation
of a fully bioabsorbable drug-eluting stent: the BVS poly-L-lactic acid
everolimus-eluting coronary stent. Catheter Cardiovasc Interv. 2007;
69:128-31.
91. Vogt F, Stein A, Rettemeier G, Krott N, Hoffmann R, vom Dahl J,
Bosserhoff AK, Michaeli W, Hanrath P, Weber C, Blindt R. Long-term
assessment of a novel biodegradable paclitaxel-eluting coronary
polylactide stent. Eur Heart J. 2004; 25:1330-40.
92. Uurto I, Mikkonen J, Parkkinen J, Keski-Nisula L, Nevalainen T,
Kellomaki M, Tormala P, Salenius JP. Drug-eluting biodegradable poly-
D/L-lactic acid vascular stents: an experimental pilot study. J Endovasc
Ther. 2005; 12:371-9.
93. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent
restenosis: contributions of inflammatory responses and arterial injury to
neointimal hyperplasia. J Am Coll Cardiol. 1998; 31:224-30.
94. Bonan R, Paiement P, Scortichini D, Cloutier MJ, Leung TK. Coronary
restenosis: evaluation of a restenosis injury index in a swine model. Am
Heart J. 1993; 126:1334-40.
95. Nikol S HB. Restenose nach Angioplastie – Interventionsmöglichkeiten.
Interventionelle Kardiologie. 2001; 361-373.
96. de Vries SO HM. Results of aortic bifurcation grafts for aortoiliac
occlusive disease: a meta-analysis. J Vasc Surg. 1997; 26:558-569.
97. Steffey EP. Some characteristics of ruminants and swine that complicate
management of general anesthesia. Vet Clin North Am Food Anim
Pract. 1986; 2:507-16.
98. Hsu TH, Gill IS, Sung GT, Meraney A, McMahon JT, Novick AC.
Laparoscopic aortorenal bypass. J Endourol. 2000; 14:123-31.
71